www.medscape.org
Open in
urlscan Pro
104.18.31.171
Public Scan
Submitted URL: http://veeva.valneva.com/c/eJx0kM1ugzAQhJ_G3IqWxTZw4ECbUlWNmlOk9rjYC7FqfuQQ6ONXaSqUS_f6zeyM5uNhTw37UmSPAnEKo72Y-dUKRJFWAp...
Effective URL: https://www.medscape.org/viewarticle/986850
Submission: On July 24 via manual from US — Scanned from DE
Effective URL: https://www.medscape.org/viewarticle/986850
Submission: On July 24 via manual from US — Scanned from DE
Form analysis 3 forms found in the DOM
Name: SearchFormHeader — GET javascript:subsearchheadertrack('en');
<form name="SearchFormHeader" class="search-form-header" method="get" aria-label="Search" action="javascript:subsearchheadertrack('en');">
<input type="hidden" value="news" name="searchSrc">
<input id="search-input" class="search-input search-input-text" aria-label="Search" type="text" autocomplete="off" autocorrect="off" name="q" maxlength="500" placeholder="Search">
<button type="submit" class="search-submit-button" aria-label="Search" title="search">
<svg xmlns="https://www.w3.org/2000/svg" viewBox="0 0 21 21">
<path fill="#005B80" fill-rule="evenodd"
d="M12.018 12.468c-2.155 2.156-5.63 2.156-7.784 0-2.155-2.154-2.155-5.63 0-7.784 2.154-2.155 5.63-2.155 7.784 0 2.155 2.155 2.133 5.63 0 7.784M2.54 2.99c-3.078 3.08-3.078 8.07 0 11.15 2.727 2.727 6.927 3.035 10.006.946l5.168 5.167c.572.572 1.517.572 2.09 0 .57-.572.57-1.517 0-2.09l-5.17-5.166c2.09-3.08 1.782-7.28-.945-10.006-3.08-3.077-8.07-3.077-11.15 0">
</path>
</svg></button>
<button type="button" class="search-open-button js-expand-button" data-section=".header-search" aria-label="Search">
<svg xmlns="https://www.w3.org/2000/svg" viewBox="0 0 21 21">
<path fill="#005B80" fill-rule="evenodd"
d="M12.018 12.468c-2.155 2.156-5.63 2.156-7.784 0-2.155-2.154-2.155-5.63 0-7.784 2.154-2.155 5.63-2.155 7.784 0 2.155 2.155 2.133 5.63 0 7.784M2.54 2.99c-3.078 3.08-3.078 8.07 0 11.15 2.727 2.727 6.927 3.035 10.006.946l5.168 5.167c.572.572 1.517.572 2.09 0 .57-.572.57-1.517 0-2.09l-5.17-5.166c2.09-3.08 1.782-7.28-.945-10.006-3.08-3.077-8.07-3.077-11.15 0">
</path>
</svg></button>
<div class="ilfulllist">
<p class="il_combo_nor">No Results</p>
<ul class="combolist"></ul>
</div>
</form>Name: SearchFormHeader — GET javascript:subsearchheadertrack('en');
<form name="SearchFormHeader" class="search-form-header" method="get" aria-label="Search" action="javascript:subsearchheadertrack('en');">
<input type="hidden" value="news" name="searchSrc">
<input id="layer-search-input" class="search-input search-input-text" aria-label="Search" type="text" autocomplete="off" autocorrect="off" name="q" maxlength="500" placeholder="Search">
<button type="submit" class="search-submit-button" aria-label="Search" title="search">
<svg xmlns="https://www.w3.org/2000/svg" viewBox="0 0 21 21">
<path fill="#005B80" fill-rule="evenodd"
d="M12.018 12.468c-2.155 2.156-5.63 2.156-7.784 0-2.155-2.154-2.155-5.63 0-7.784 2.154-2.155 5.63-2.155 7.784 0 2.155 2.155 2.133 5.63 0 7.784M2.54 2.99c-3.078 3.08-3.078 8.07 0 11.15 2.727 2.727 6.927 3.035 10.006.946l5.168 5.167c.572.572 1.517.572 2.09 0 .57-.572.57-1.517 0-2.09l-5.17-5.166c2.09-3.08 1.782-7.28-.945-10.006-3.08-3.077-8.07-3.077-11.15 0">
</path>
</svg></button>
<div class="ilfulllist">
<p class="il_combo_nor">No Results</p>
<ul class="combolist"></ul>
</div>
</form><form id="cme-form-Q-3">
<input type="hidden" value="3" name="formid">
<h2>Question 1 of 4</h2>
<fieldset>
<div class="cme-question is-required" id="cme-question-567745" data-question-id="567745">
<input type="hidden" value="567745" name="questionId">
<legend>
<div class="question-content">
<p>Which of the following countries reported several hundred locally transmitted cases of chikungunya virus in 2017?</p>
</div>
</legend>
<label for="answer-1756987-1">
<input type="radio" value="1756987" id="answer-1756987-1" name="1" data-question-id="567745">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Croatia</p>
</div>
</label>
<label for="answer-1756988-1">
<input type="radio" value="1756988" id="answer-1756988-1" name="1" data-question-id="567745">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Greece</p>
</div>
</label>
<label for="answer-1756989-1">
<input type="radio" value="1756989" id="answer-1756989-1" name="1" data-question-id="567745">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Italy</p>
</div>
</label>
<label for="answer-1756990-1">
<input type="radio" value="1756990" id="answer-1756990-1" name="1" data-question-id="567745">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Japan</p>
</div>
</label>
</div>
</fieldset>
<h2>Question 2 of 4</h2>
<fieldset>
<div class="cme-question is-required" id="cme-question-567746" data-question-id="567746">
<input type="hidden" value="567746" name="questionId">
<legend>
<div class="question-content">
<p>Which of the following develops in at least 40% of people following chikungunya infection?</p>
</div>
</legend>
<label for="answer-1756991-2">
<input type="radio" value="1756991" id="answer-1756991-2" name="2" data-question-id="567746">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Arthritis</p>
</div>
</label>
<label for="answer-1756992-2">
<input type="radio" value="1756992" id="answer-1756992-2" name="2" data-question-id="567746">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Bone fracture</p>
</div>
</label>
<label for="answer-1756993-2">
<input type="radio" value="1756993" id="answer-1756993-2" name="2" data-question-id="567746">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Gastritis</p>
</div>
</label>
<label for="answer-1756994-2">
<input type="radio" value="1756994" id="answer-1756994-2" name="2" data-question-id="567746">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Hearing loss</p>
</div>
</label>
</div>
</fieldset>
<h2>Question 3 of 4</h2>
<fieldset>
<div class="cme-question is-required" id="cme-question-567747" data-question-id="567747">
<input type="hidden" value="567747" name="questionId">
<legend>
<div class="question-content">
<p>Chikungunya symptoms are particularly similar to those of which 2 other vector-borne diseases?</p>
</div>
</legend>
<label for="answer-1756995-3">
<input type="radio" value="1756995" id="answer-1756995-3" name="3" data-question-id="567747">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Leishmaniasis and yellow fever</p>
</div>
</label>
<label for="answer-1756996-3">
<input type="radio" value="1756996" id="answer-1756996-3" name="3" data-question-id="567747">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>West Nile fever and Zika</p>
</div>
</label>
<label for="answer-1756997-3">
<input type="radio" value="1756997" id="answer-1756997-3" name="3" data-question-id="567747">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Dengue and Zika</p>
</div>
</label>
<label for="answer-1756998-3">
<input type="radio" value="1756998" id="answer-1756998-3" name="3" data-question-id="567747">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>Malaria and Japanese encephalitis</p>
</div>
</label>
</div>
</fieldset>
<h2>Question 4 of 4</h2>
<fieldset>
<div class="cme-question is-required" id="cme-question-567748" data-question-id="567748">
<input type="hidden" value="567748" name="questionId">
<legend>
<div class="question-content">
<p>How confident are you right now in your ability to advise travelers about their risk of acquiring chikungunya virus infection? (Select ranking from 1 [Not confident] to 5 [Very confident])</p>
</div>
</legend>
<label for="answer-1756999-4">
<input type="radio" value="1756999" id="answer-1756999-4" name="4" data-question-id="567748">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>1 - Not confident</p>
</div>
</label>
<label for="answer-1757000-4">
<input type="radio" value="1757000" id="answer-1757000-4" name="4" data-question-id="567748">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>2 - Slightly confident</p>
</div>
</label>
<label for="answer-1757001-4">
<input type="radio" value="1757001" id="answer-1757001-4" name="4" data-question-id="567748">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>3 - Moderately confident</p>
</div>
</label>
<label for="answer-1757002-4">
<input type="radio" value="1757002" id="answer-1757002-4" name="4" data-question-id="567748">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>4 - Mostly confident</p>
</div>
</label>
<label for="answer-1757003-4">
<input type="radio" value="1757003" id="answer-1757003-4" name="4" data-question-id="567748">
<div class="answer-content">
<ans>
<span></span>
</ans>
<p>5 - Very confident</p>
</div>
</label>
</div>
</fieldset>
<div id="cme-form-actions"><a href="javascript:;" class="cme-button disabled" onclick="wmdPageLink("vwart-qna_svprc")">Save and Proceed</a></div>
</form>Text Content
This site is intended for healthcare professionals
You are leaving Medscape Education
Cancel Continue
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Interprofessional
Shared Decision Making
Nurses
Pharmacists
Edition: English
Medscape
English
Deutsch
Español
Français
Português
UKNew
Univadis
Français New
Italiano New
Log In
Sign Up It's Free!
English Edition
Medscape
* English
* Deutsch
* Español
* Français
* Português
* UKNew
Univadis
* Français New
* Italiano New
X
Univadis from Medscape
Register Log In
No Results
No Results
Monday, July 24, 2023
News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
Log in to save activities Your saved activities will show here so that you can
easily access them whenever you're ready. Log in here CME & Education
close
Please confirm that you would like to log out of Medscape. If you log out, you
will be required to enter your username and password the next time you visit.
Log out Cancel
FACULTY AND DISCLOSURES
Medscape, LLC requires every individual in a position to control educational
content to disclose all financial relationships with ineligible companies that
have occurred within the past 24 months. Ineligible companies are organizations
whose primary business is producing, marketing, selling, re-selling, or
distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the
content of this educational activity are listed below and have been mitigated.
Others involved in the planning of this activity have no relevant financial
relationships.
FACULTY
*
* TOMAS JELINEK, MD
Medical Director
Berlin Centre for Travel and Tropical Medicine
Berlin, Germany
Disclosures
Tomas Jelinek, MD, has the following relevant financial relationships:
Consultant or advisor for: Bavarian Nordic; India Serum Institute; Janssen;
Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur; Takeda;
Valneva
Speaker or member of speakers bureau for: Astella; AstraZeneca; Bavarian
Nordic; Baxter; BioNTech; GlaxoSmithKline; Glenmark; Hermes Arzneimittel;
Hoffmann LaRoche; Janssen; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.;
Sanofi Pasteur; Takeda; Valneva
Research funding from: Glenmark; Takeda
Contracted researcher for: BioNTech; GlaxoSmithKline; Janssen; Merck Sharp &
Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur; Takeda; Valneva
*
* LIN H. CHEN, MD, FACP, FASTMH, FISTM
Director
Mount Auburn Travel Medicine Center
Associate Professor
Harvard Medical School
Division of Infectious Diseases and Travel Medicine
Mount Auburn Hospital
Cambridge, MA, United States
Disclosures
Lin H. Chen, MD, FACP, FASTMH, FISTM, has the following relevant financial
relationships:
Consultant or advisor for: Emergent BioSolutions; Merck; Sanofi Pasteur;
Shoreland; Takeda; Valneva
Research funding from: Sanofi Pasteur
EDITOR
* GILLIAN GRIFFITH, BA (MOD), MA
Medical Education Director, WebMD Global, LLC
Disclosures
Gillian Griffith, BA (Mod), MA, has no relevant financial relationships.
COMPLIANCE REVIEWER
* SUSAN L. SMITH, MN, PHD
Associate Director, Accreditation and Compliance, Medscape, LLC
Disclosures
Susan L. Smith, MN, PhD, has no relevant financial relationships.
PEER REVIEWER
This activity has been peer reviewed and the reviewer has no relevant financial
relationships.
x
0.50 CME / ABIM MOC
CME / ABIM MOC
CHIKUNGUNYA VIRUS: EPIDEMIOLOGY, OUTBREAKS, AND CLINICAL CHARACTERISTICS
Do you know who is at risk from chikungunya infection?
Authors: Tomas Jelinek, MD; Lin H. Chen, MD, FACP, FASTMH, FISTM
* Authors: Tomas Jelinek, MD; Lin H. Chen, MD, FACP, FASTMH, FISTM
* CME / ABIM MOC Released: 1/26/2023
* Valid for credit through: 1/26/2024
Start Activity
Log In to Start
*
* --------------------------------------------------------------------------------
CREDITS AVAILABLE
Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™
ABIM Diplomates - maximum of 0.50 ABIM MOC points
YOU ARE ELIGIBLE FOR
* Letter of Completion
* ABIM MOC points
*
--------------------------------------------------------------------------------
TARGET AUDIENCE AND GOAL STATEMENT
This activity is intended for primary care physicians and infectious disease
specialists.
The goal of this activity is for learners to be more knowledgeable about the
epidemiology, clinical presentation, and burden of chikungunya virus.
Upon completion of this activity, participants will:
* Have increased knowledge regarding
* The epidemiology of chikungunya
* The disease burden of chikungunya
* The diagnosis of chikungunya
--------------------------------------------------------------------------------
DISCLOSURES
Medscape, LLC requires every individual in a position to control educational
content to disclose all financial relationships with ineligible companies that
have occurred within the past 24 months. Ineligible companies are organizations
whose primary business is producing, marketing, selling, re-selling, or
distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the
content of this educational activity are listed below and have been mitigated.
Others involved in the planning of this activity have no relevant financial
relationships.
--------------------------------------------------------------------------------
FACULTY
*
* TOMAS JELINEK, MD
Medical Director
Berlin Centre for Travel and Tropical Medicine
Berlin, Germany
Tomas Jelinek, MD, has the following relevant financial relationships:
Consultant or advisor for: Bavarian Nordic; India Serum Institute; Janssen;
Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur; Takeda;
Valneva
Speaker or member of speakers bureau for: Astella; AstraZeneca; Bavarian
Nordic; Baxter; BioNTech; GlaxoSmithKline; Glenmark; Hermes Arzneimittel;
Hoffmann LaRoche; Janssen; Merck Sharp & Dohme; Moderna, Inc.; Pfizer, Inc.;
Sanofi Pasteur; Takeda; Valneva
Research funding from: Glenmark; Takeda
Contracted researcher for: BioNTech; GlaxoSmithKline; Janssen; Merck Sharp &
Dohme; Moderna, Inc.; Pfizer, Inc.; Sanofi Pasteur; Takeda; Valneva
Disclosure +
*
* LIN H. CHEN, MD, FACP, FASTMH, FISTM
Director
Mount Auburn Travel Medicine Center
Associate Professor
Harvard Medical School
Division of Infectious Diseases and Travel Medicine
Mount Auburn Hospital
Cambridge, MA, United States
Lin H. Chen, MD, FACP, FASTMH, FISTM, has the following relevant financial
relationships:
Consultant or advisor for: Emergent BioSolutions; Merck; Sanofi Pasteur;
Shoreland; Takeda; Valneva
Research funding from: Sanofi Pasteur
Disclosure +
EDITOR
* GILLIAN GRIFFITH, BA (MOD), MA
Medical Education Director, WebMD Global, LLC
Gillian Griffith, BA (Mod), MA, has no relevant financial relationships.
Disclosure +
COMPLIANCE REVIEWER
* SUSAN L. SMITH, MN, PHD
Associate Director, Accreditation and Compliance, Medscape, LLC
Susan L. Smith, MN, PhD, has no relevant financial relationships.
Disclosure +
PEER REVIEWER
This activity has been peer reviewed and the reviewer has no relevant financial
relationships.
--------------------------------------------------------------------------------
ACCREDITATION STATEMENTS
In support of improving patient care, Medscape, LLC is jointly accredited with
commendation by the Accreditation Council for Continuing Medical Education
(ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide continuing education for
the healthcare team.
FOR PHYSICIANS
* Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA
Category 1 Credit(s)™ . Physicians should claim only the credit commensurate
with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in
the evaluation component, enables the participant to earn up to 0.50 MOC
points in the American Board of Internal Medicine's (ABIM) Maintenance of
Certification (MOC) program. Participants will earn MOC points equivalent to
the amount of CME credits claimed for the activity. It is the CME activity
provider's responsibility to submit participant completion information to
ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data
will be shared with commercial supporters of this activity.
Contact This Provider
For questions regarding the content of this activity, contact the accredited
provider for this CME/CE activity noted above. For technical assistance, contact
CME@medscape.net
--------------------------------------------------------------------------------
INSTRUCTIONS FOR PARTICIPATION AND CREDIT
There are no fees for participating in or receiving credit for this online
educational activity. For information on applicability and acceptance of
continuing education credit for this activity, please consult your professional
licensing board.
This activity is designed to be completed within the time designated on the
title page; physicians should claim only those credits that reflect the time
actually spent in the activity. To successfully earn credit, participants must
complete the activity online during the valid credit period that is noted on the
title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum
score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
1. Read about the target audience, learning objectives, and author disclosures.
2. Study the educational content online or print it out.
3. Online, choose the best answer to each test question. To receive a
certificate, you must receive a passing score as designated at the top of
the test. We encourage you to complete the Activity Evaluation to provide
feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may
print the certificate, but you cannot alter it. Credits will be tallied in your
CME/CE Tracker and archived for 6 years; at any point within this time period,
you can print out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
Log In to Start
* Print
* Like Tweet
* 6
*
* ALL CREDITS AVAILABLE
PhysiciansMaximum of 0.50 AMA PRA Category 1 Credit(s)™
ABIM DiplomatesMaximum of 0.50 ABIM MOC points
CME / ABIM MOC Released: 1/26/2023
Valid for credit through: 1/26/2024
From Medscape Education
CME / ABIM MOC
CHIKUNGUNYA VIRUS: EPIDEMIOLOGY, OUTBREAKS, AND CLINICAL CHARACTERISTICS
Authors: Tomas Jelinek, MD; Lin H. Chen, MD, FACP, FASTMH, FISTMFaculty and
Disclosures
CME / ABIM MOC Released: 1/26/2023
Valid for credit through: 1/26/2024
processing....
CME Info & Disclosures
* None
* Français
* Deutsch
EDUCATIONAL IMPACT CHALLENGE
The goal of this activity is for learners to be more knowledgeable about the
epidemiology, clinical presentation, and burden of chikungunya virus.
Before you begin this activity, please assess your clinical knowledge by
completing this brief survey. Answering these questions again after the activity
will allow you to see what you learned and to compare your answers with those of
your peers.
QUESTION 1 OF 4
Which of the following countries reported several hundred locally transmitted
cases of chikungunya virus in 2017?
Croatia
Greece
Italy
Japan
QUESTION 2 OF 4
Which of the following develops in at least 40% of people following chikungunya
infection?
Arthritis
Bone fracture
Gastritis
Hearing loss
QUESTION 3 OF 4
Chikungunya symptoms are particularly similar to those of which 2 other
vector-borne diseases?
Leishmaniasis and yellow fever
West Nile fever and Zika
Dengue and Zika
Malaria and Japanese encephalitis
QUESTION 4 OF 4
How confident are you right now in your ability to advise travelers about their
risk of acquiring chikungunya virus infection? (Select ranking from 1 [Not
confident] to 5 [Very confident])
1 - Not confident
2 - Slightly confident
3 - Moderately confident
4 - Mostly confident
5 - Very confident
Save and Proceed
Page 1 of 4
Download Slides
* Activity Transcript
* Canadian Expert Commentary
* Print
* Like Tweet
* 6
* Activity Transcript
* Sous-titres en français
* Deutsche Untertitel
* Canadian Expert Commentary
Disclaimer
The educational activity presented above may involve simulated, case-based
scenarios. The patients depicted in these scenarios are fictitious and no
association with any actual patient, whether living or deceased, is intended or
should be inferred. The material presented here does not necessarily reflect the
views of Medscape, LLC, or any individuals or commercial entities that support
companies that support educational programming on medscape.org. These materials
may include discussion of therapeutic products that have not been approved by
the US Food and Drug Administration, off-label uses of approved products, or
data that were presented in abstract form. These data should be considered
preliminary until published in a peer-reviewed journal. Readers should verify
all information and data before treating patients or employing any therapies
described in this or any educational activity. A qualified healthcare
professional should be consulted before using any therapeutic product discussed
herein.
Medscape Education © 2023 Medscape, LLC
Find Us On
About
About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms
of Use Advertising Policy Help Center
Membership
Become a Member About You Professional Information Newsletters & Alerts Market
Research
App
Medscape
WebMD Network
Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate
Medscape UK
Editions
English Deutsch Español Français Português UK
All material on this website is protected by copyright, Copyright © 1994-2023 by
WebMD LLC. This website also contains material copyrighted by 3rd parties.
Close
YOUR PRIVACY AND MANAGE COOKIES
We process your data to deliver content or advertisements and measure the
delivery of such content or advertisements to extract insights about our
website. We share this information with our partners on the basis of consent and
legitimate interest. You may exercise your right to consent or object to a
legitimate interest, based on a specific purpose below or at a partner level in
the link under each purpose. These choices will be signaled to our vendors
participating in the Transparency and Consent Framework.
More Information
Allow All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY COOKIES
Always Active
These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.
PERFORMANCE COOKIES
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.
TARGETING COOKIES
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.
FUNCTIONAL COOKIES
Functional Cookies
These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.
STORE AND/OR ACCESS INFORMATION ON A DEVICE
Store and/or access information on a device
Cookies, device identifiers, or other information can be stored or accessed on
your device for the purposes presented to you.
List of IAB Vendors | View Full Legal Text Opens in a new Tab
PERSONALISED ADS AND CONTENT, AD AND CONTENT MEASUREMENT, AUDIENCE INSIGHTS AND
PRODUCT DEVELOPMENT
Personalised ads and content, ad and content measurement, audience insights and
product development
* SELECT BASIC ADS
Switch Label
Ads can be shown to you based on the content you’re viewing, the app you’re
using, your approximate location, or your device type.
Object to Legitimate Interests Remove Objection
* CREATE A PERSONALISED ADS PROFILE
Switch Label
A profile can be built about you and your interests to show you personalised
ads that are relevant to you.
Object to Legitimate Interests Remove Objection
* SELECT PERSONALISED ADS
Switch Label
Personalised ads can be shown to you based on a profile about you.
Object to Legitimate Interests Remove Objection
* CREATE A PERSONALISED CONTENT PROFILE
Switch Label
A profile can be built about you and your interests to show you personalised
content that is relevant to you.
Object to Legitimate Interests Remove Objection
* SELECT PERSONALISED CONTENT
Switch Label
Personalised content can be shown to you based on a profile about you.
Object to Legitimate Interests Remove Objection
* MEASURE AD PERFORMANCE
Switch Label
The performance and effectiveness of ads that you see or interact with can be
measured.
Object to Legitimate Interests Remove Objection
* MEASURE CONTENT PERFORMANCE
Switch Label
The performance and effectiveness of content that you see or interact with
can be measured.
Object to Legitimate Interests Remove Objection
* APPLY MARKET RESEARCH TO GENERATE AUDIENCE INSIGHTS
Switch Label
Market research can be used to learn more about the audiences who visit
sites/apps and view ads.
Object to Legitimate Interests Remove Objection
* DEVELOP AND IMPROVE PRODUCTS
Switch Label
Your data can be used to improve existing systems and software, and to
develop new products
Object to Legitimate Interests Remove Objection
List of IAB Vendors | View Full Legal Text Opens in a new Tab
USE PRECISE GEOLOCATION DATA
Use precise geolocation data
Your precise geolocation data can be used in support of one or more purposes.
This means your location can be accurate to within several meters.
List of IAB Vendors | View Full Legal Text Opens in a new Tab
ACTIVELY SCAN DEVICE CHARACTERISTICS FOR IDENTIFICATION
Actively scan device characteristics for identification
Your device can be identified based on a scan of your device's unique
combination of characteristics.
List of IAB Vendors | View Full Legal Text Opens in a new Tab
ENSURE SECURITY, PREVENT FRAUD, AND DEBUG
Always Active
Your data can be used to monitor for and prevent fraudulent activity, and ensure
systems and processes work properly and securely.
List of IAB Vendors | View Full Legal Text Opens in a new Tab
TECHNICALLY DELIVER ADS OR CONTENT
Always Active
Your device can receive and send information that allows you to see and interact
with ads and content.
List of IAB Vendors | View Full Legal Text Opens in a new Tab
MATCH AND COMBINE OFFLINE DATA SOURCES
Always Active
Data from offline data sources can be combined with your online activity in
support of one or more purposes
List of IAB Vendors | View Full Legal Text Opens in a new Tab
LINK DIFFERENT DEVICES
Always Active
Different devices can be determined as belonging to you or your household in
support of one or more of purposes.
List of IAB Vendors | View Full Legal Text Opens in a new Tab
RECEIVE AND USE AUTOMATICALLY-SENT DEVICE CHARACTERISTICS FOR IDENTIFICATION
Always Active
Your device might be distinguished from other devices based on information it
automatically sends, such as IP address or browser type.
List of IAB Vendors | View Full Legal Text Opens in a new Tab
Back Button
PERFORMANCE COOKIES
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Confirm My Choices
YOUR CHOICE ON COOKIES
We and our partners store and/or access information on a device, such as unique
IDs in cookies to process personal data. You may accept or manage your choices
by clicking below, including your right to object where legitimate interest is
used, or at any time in the privacy policy page. These choices will be signaled
to our partners and will not affect browsing data.See our Cookie Notice.
WE AND OUR PARTNERS PROCESS DATA TO:
Use precise geolocation data. Actively scan device characteristics for
identification. Store and/or access information on a device. Personalised ads
and content, ad and content measurement, audience insights and product
development. List of Partners
I Accept Manage Settings